Close Menu

biomarker discovery

NEW YORK (GenomeWeb News) – A non-profit organization called the National Biomarker Development Alliance has launched to develop standards and guidelines for supporting biomarker development and use, the NBDA said today.

NEW YORK (GenomeWeb News) — Exosome Diagnostics said today that it has entered into a collaboration agreement with Eli Lilly for biomarker discovery and validation using Exosome's EXO50 nucleic acid extraction kit.

NEW YORK (GenomeWeb News) – Bruker said today at the 12th annual meeting of the Human Proteome Organization in Yokohama, Japan, that it has launched a second-phase collaboration agreement with SISCAPA Assays Technologies to apply the SISCAPA immunoenrichment mass spec method to its MALDI-TOF inst

NEW YORK (GenomeWeb News) – The University of Manchester's Institute of Cancer Sciences said today that it will lead an international consortium that will use €6 million ($7.9 million) in funding to develop genetic biomarkers to identify patients who are at risk of developing long-term side effec

NEW YORK (GenomeWeb News) – The European Union plans to fund new research seeking to establish the clinical utility of epigenetic biomarkers for blood-based diseases under its Blueprint consortium program, a €30 million ($39.8 million) effort focused on advancing hematopoietic biomarkers.

NEW YORK (GenomeWeb News) – Ten institutes at the National Institutes of Health plan to provide $17.5 million in funding next year to support a network of as many as 14 consortia that will pursue clinica

NEW YORK (GenomeWeb News) – A consortium led by the University of Texas Health Science Center at San Antonio has received a five-year award for up to $45 million from the US Department of Defense and US Department of Veterans Affairs to use next-generation sequencing and mass spectrometry to cond

NEW YORK (GenomeWeb News) – Biopharmaceutical firm Berg and the US Department of Defense today announced an agreement to discover biomarkers for prostate cancer and to develop more effective treatments for the disease.

NEW YORK (GenomeWeb News) – A 14-member consortium of European companies and academic partners have been awarded €6 million ($7.7 million) from the EU to use genomics technologies to develop biomarker-driven personalized vaccines for glioma patients.

NEW YORK (GenomeWeb News) – Genewiz and the John Theurer Cancer Center at Hackensack University Medical Center today announced a collaboration for the discovery of ovarian cancer biomarkers.

Pages

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.